Evaluation of symptom control and functional quality of life in Turkish patients with cancer during chemotherapy
European Journal of Oncology Nursing, cilt.61, 2022 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 61
- Basım Tarihi: 2022
- Doi Numarası: 10.1016/j.ejon.2022.102239
- Dergi Adı: European Journal of Oncology Nursing
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, ASSIA, CINAHL, EMBASE, MEDLINE, Psycinfo
- Anahtar Kelimeler: Cancer patient, Nursing care, Quality of life, Symptom control
- Trakya Üniversitesi Adresli: Evet
Özet
Purpose: This study was designed to evaluate the severity of symptoms, functional quality of life, and related factors experienced by Turkish cancer patients receiving chemotherapy. Methods: The study was carried out with 430 patients at a medical oncology clinic. The data were collected using a personal and disease-related characteristics questionnaire, the Edmonton Symptom Assessment Scale (ESAS) and the Functional Life Scale–Cancer (FLIC). Results: The three symptoms experienced most by patients were nausea (91.2%), depression (89.1%), and anxiety (87.7%). The mean FLIC total score of patients with cancer was 86.26 ± 23.15. Age, ECOG performance score, pain, nausea, depression, and a decreased sense of well-being independently affected the FLIC score (p < 0.05). There was a negative correlation between ESAS and FLIC scores (p < 0.05). Conclusion: Nausea and psychological symptoms are common in Turkish patients with cancer. The more severe the symptoms, the worse the functional quality of life. Age, ECOG performance score, pain, nausea, depression, and decreased sense of well-being affect Turkish cancer patients’ functional quality of life. We conclude that healthcare professionals should evaluate symptoms experienced by their patients and plan appropriate nursing interventions to address the symptoms experienced by Turkish patients with cancer.